Immunotherapeutic uses of CpG oligodeoxynucleotides.
Klinman
Dennis M
DM
CBER/FDA, Bethesda, Maryland 20892, USA. klinman@cber.FDA.gov
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D018899:CpG Islands / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D009838:Oligodeoxyribonucleotides / Q000627:therapeutic use*; D015398:Signal Transduction / Q000276:immunology*
D000942:Antigens, Bacterial; D009838:Oligodeoxyribonucleotides